Adam Fridhammar

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Glycemic Control

Breast Cancer Risk

Health Promotion

Sentinel Lymph Node

Top Venues

PharmacoEconomics - open

PharmacoEconomics

Breast cancer research and treatment

Swedish Institute for Health Economics

Lund Universitet Nationalekonomiska institutionen (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Swedish Institute for Health Economics Sep 01 2011

Sweden

Research Analyst

Education History

Lund Universitet Nationalekonomiska institutionen

Sweden

MSC

Publications

Ida Skarping, Kristoffer Nilsson, Looket Dihge, Adam Fridhammar, Mattias Ohlsson, Linnea Huss, Pär-Ola Bendahl, Katarina Steen Carlsson, Lisa Rydén
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer. Breast cancer research and treatment 194 (3) (2022)
Michael Willis, Adam Fridhammar, Jens Gundgaard, Andreas Nilsson, Pierre Johansen
Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM. PharmacoEconomics 38 (9) (2021)
Adam Fridhammar, Ulrika Axelsson, Ulf Persson, Anders Bjartell, Carl A K Borrebaeck
The Value of a New Diagnostic Test for Prostate Cancer: A Cost-Utility Analysis in Early Stage of Development. PharmacoEconomics - open (2020)